Matthew Sikora, PhD, of the University of Colorado Cancer Center, is leading research on a growing subtype of breast cancer that often evades standard screening and contributes to lower survival rates. His work focuses on uncovering the molecular and genetic traits driving this elusive disease to improve early detection and personalized treatment.